Key regulators in the RTK-ERK1/2 signaling network are frequently mutated in a family of developmental syndromes known collectively as the ‘RASopathies’ (Jindal et al., 2015; Kim and Baek, 2019; Rauen, 2013, 2022). Here, MAPK3 is linked to RASopathy.